ATAD5 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 6.560000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
6.858400E-01
Normal-vs-Stage2
6.691200E-01
Normal-vs-Stage3
4.775000E-01
Normal-vs-Stage4
5.839800E-01
Stage1-vs-Stage2
9.493800E-01
Stage1-vs-Stage3
5.825400E-01
Stage1-vs-Stage4
9.175000E-01
Stage2-vs-Stage3
5.503800E-01
Stage2-vs-Stage4
9.459800E-01
Stage3-vs-Stage4
6.555400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
6.643800E-01
Normal-vs-AfricanAmerican
6.615200E-01
Normal-vs-Asian
5.310200E-01
Caucasian-vs-AfricanAmerican
6.594400E-01
Caucasian-vs-Asian
1.676040E-01
AfricanAmerican-vs-Asian
4.044200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
6.336600E-01
Normal-vs-Female
6.883400E-01
Male-vs-Female
3.006400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.454000E-01
Normal-vs-Age(41-60Yrs)
6.794400E-01
Normal-vs-Age(61-80Yrs)
6.479200E-01
Normal-vs-Age(81-100Yrs)
6.826800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.392800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.005800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.880800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
5.923600E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
9.992600E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
7.796200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
5.865600E-01
Normal-vs-Daily Drinker
6.023200E-01
Normal-vs-Weekly Drinker
6.368800E-01
Normal-vs-Occasional Drinker
6.677600E-01
Normal-vs-Social Drinker
7.819400E-01
Non Drinker-vs-Daily Drinker
8.608600E-01
Non Drinker-vs-Weekly Drinker
6.026800E-01
Non Drinker-vs-Occasional Drinker
3.830400E-01
Non Drinker-vs-Social Drinker
5.240400E-02
Daily Drinker-vs-Weekly Drinker
7.661400E-01
Daily Drinker-vs-Occasional Drinker
5.560000E-01
Daily Drinker-vs-Social Drinker
1.394830E-01
Weekly Drinker-vs-Occasional Drinker
8.002000E-01
Weekly Drinker-vs-Social Drinker
2.715200E-01
Occasional Drinker-vs-Social Drinker
3.835000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
6.833600E-01
Normal-vs-Grade 2
4.162600E-01
Normal-vs-Grade 3
2.526400E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.525600E-01
Grade 1-vs-Grade 3
4.404100E-02
Grade 1-vs-Grade 4
6.833600E-01
Grade 2-vs-Grade 3
1.658040E-01
Grade 2-vs-Grade 4
4.162600E-01
Grade 3-vs-Grade 4
2.526400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
5.662600E-01
Normal-vs-NonDiabetic
6.494000E-01
Diabetic-vs-NonDiabetic
1.313350E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
7.273200E-01
Normal-vs-NoPancreatitis
6.228800E-01
Pancreatitis-vs-NoPancreatitis
3.208800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
6.854400E-01
Normal-vs-N1
6.513800E-01
N0-vs-N1
5.791400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
8.340000E-01
Normal-vs-TP53-NonMutant
6.821800E-01
TP53-Mutant-vs-TP53-NonMutant
5.868300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
